SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-017651
Filing Date
2024-05-20
Accepted
2024-05-20 16:09:10
Documents
14
Period of Report
2024-05-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cont20240420_8k.htm   iXBRL 8-K 30654
  Complete submission text file 0001437749-24-017651.txt   168407

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA noticker-20240520.xsd EX-101.SCH 3441
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20240520_def.xml EX-101.DEF 11816
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20240520_lab.xml EX-101.LAB 15848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20240520_pre.xml EX-101.PRE 12031
17 EXTRACTED XBRL INSTANCE DOCUMENT cont20240420_8k_htm.xml XML 2966
Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

IRS No.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42001 | Film No.: 24964501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)